02380 408 600 Contact us Book a course

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

Menu

×

Home
Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training
Who we are
Information & News

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

Post navigation

Previous: Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data

Next: Prescription-event monitoring and reporting of adverse drug reactions

Interested in conducting a study?

Get in touch today to discuss your requirements

Services

Conducting Studies
Consulting
Institute of Pharmacovigilance Sciences
Education & Training

Information

Publications
DSRU News
Press
General Practitioners
Conference Abstracts

Organisation

About Us
Meet The Team
Job Vacancies
Privacy Policy
Terms & Conditions

© 2023 DSRU - Bursledon Hall, Blundell Lane, Southampton, SO31 1AA | Registered Charity No. 327206 | Designed & developed by Dolia